Arcturus Therapeutics Holdings Inc.
ARCT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001768224
No open-market purchases or sales by Arcturus Therapeutics Holdings Inc. insiders were filed in the last 90 days; 135 institutions reported holding it in 13F filings for Q2 2026, worth $167.9M in total; ARK Invest is the only superinvestor holding it.
Q2 2022 vs. Q1 2022
How the institutions holding Arcturus Therapeutics Holdings Inc. changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Of which not filed for Q2 2022 | Q2 2022 | Change |
|---|---|---|---|---|
| Holders | 129 | 3 | 128 | +2 |
| Shares | 21.4M | 44.6K | 22.2M | +748.9K (+3.5%) |
| Value | $578.1M | $1.20M | $353.6M | −$223.3M (−38.7%) |
3 institutions that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (16)
Institutions that held Arcturus Therapeutics Holdings Inc. at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Millennium Management LLC | 204,596 | $3.22M | 0.00% |
| Walleye Capital LLC | 67,978 | $1.07M | 0.03% |
| Boothbay Fund Management, LLC | 61,700 | $971.0K | 0.03% |
| Gsa Capital Partners LLP | 51,848 | $816.0K | 0.12% |
| Dynamic Technology Lab Private Ltd | 35,030 | $551.0K | 0.06% |
| Group One Trading, L.P. | 31,496 | $496.0K | 0.01% |
| Jump Financial, LLC | 24,954 | $393.0K | 0.02% |
| SG Americas Securities, LLC | 22,678 | $357.0K | 0.00% |
| Diametric Capital, LP | 22,499 | $354.0K | 0.26% |
| New York Life Investment Management LLC | 17,297 | $272.0K | 0.00% |
| Caption Management, LLC | 15,000 | $236.0K | 0.02% |
| Prelude Capital Management, LLC | 11,753 | $185.0K | 0.01% |
| Balyasny Asset Management LLC | 10,809 | $170.0K | 0.00% |
| Advisors Asset Management, Inc. | 2,330 | $37.0K | 0.00% |
| Bell Investment Advisors, Inc | 38 | $1.00K | 0.00% |
| Lindbrook Capital, LLC | 14 | $0 | 0.00% |
Sold out (14)
Institutions that held Arcturus Therapeutics Holdings Inc. at the end of Q1 2022 and filed for Q2 2022 without it.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Granahan Investment Management Inc | 64,851 | $1.75M |
| Simplex Trading, LLC | 19,710 | $531.0K |
| UBS Asset Management Americas Inc | 17,692 | $477.0K |
| LPL Financial LLC | 13,041 | $352.0K |
| Manufacturers Life Insurance Company, The | 8,352 | $225.2K |
| Bayesian Capital Management, LP | 8,300 | $224.0K |
| Voya Investment Management LLC | 8,282 | $223.0K |
| Allspring Global Investments Holdings, LLC | 838 | $22.0K |
| Old Second National Bank of Aurora | 200 | $5.00K |
| Prospera Financial Services Inc | 100 | $3.00K |
| Toth Financial Advisory Corp | 30 | $1.00K |
| Quadrant Capital Group LLC | 21 | $1.00K |
| Glassman Wealth Services | 1 | $0 |
| Concord Wealth Partners | 3 | $0 |
Not filed for Q2 2022 yet (3)
Institutions that held Arcturus Therapeutics Holdings Inc. at the end of Q1 2022 and haven't filed a 13F for Q2 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Susquehanna Fundamental Investments, LLC | 27,841 | $751.0K |
| IndexIQ Advisors LLC | 14,183 | $382.0K |
| Amalgamated Financial Corp. | 2,542 | $69.0K |